The drugmaker has won an appeal against NICE's recent final draft guidance on Sarclisa (isatuximab) as a regimen alongside ...

Myeloma UK said the illness was treatable in the majority of cases despite there being no known cure. "Treatment is aimed at controlling the disease, relieving the complications and symptoms it ...

Sanofi has hit back on a decision by NICE not ... Shelagh McKinlay, director of research and advocacy at patient organisation Myeloma UK, said the decision is “a huge blow” to patients ...

Healx will use its AI-based drug discovery tech to analyze proprietary Sanofi compound data and identify potential rare ...

CAMBRIDGE, England--(BUSINESS WIRE)--Healx, an AI-enabled, clinical-stage biotech company specialising in rare diseases, today announced it will use a Sanofi compound to identify new disease ...

Dietmar Berger, M.D., Ph.D. Chief Medical Officer, Global Head of Development at Sanofi "The positive CHMP opinion is an important step forward for people with transplant-ineligible newly diagnosed ...